✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Raaj Medisafe India Ltd.

RAAJMEDI

Market Cap
₹105 Cr.
P/E
31.31

Raaj Medisafe India Ltd.

  • Raaj Medisafe India
  • Hemant Surgical Inds
  • Holmarc Opto-Mech
FAQs on Raaj Medisafe India Ltd. Shareprice

Raaj Medisafe India has given better returns compared to its competitors.
Raaj Medisafe India has grown at ~30.02% over the last 1yrs while peers have grown at a median rate of -13.64%

Yes, Raaj Medisafe India is expensive.
Latest PE of Raaj Medisafe India is 31.31, while 3 year average PE is 15.82.
Also latest EV/EBITDA of Raaj Medisafe India is 16.96 while 3yr average is 16.42.

View FAQ's On Business
Growth Table
  • Raaj Medisafe India Ltd.
  • Hemant Surgical Inds
  • Holmarc Opto-Mech
Balance Sheet
  • Raaj Medisafe India Ltd.
  • Hemant Surgical Inds
  • Holmarc Opto-Mech
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Raaj Medisafe India Ltd.
  • Hemant Surgical Inds
  • Holmarc Opto-Mech
Cash Flow
  • Raaj Medisafe India Ltd.
  • Hemant Surgical Inds
  • Holmarc Opto-Mech
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Raaj Medisafe India Ltd.
  • Hemant Surgical Inds
  • Holmarc Opto-Mech
Quarterly Results
  • Raaj Medisafe India Ltd.
  • Hemant Surgical Inds
  • Holmarc Opto-Mech
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Raaj Medisafe India Ltd. Financials

Balance sheet of Raaj Medisafe India is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Raaj Medisafe India is increasing.
Latest net debt of Raaj Medisafe India is ₹27.96 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹25.78 Crs.

Yes, profit is increasing.
The profit of Raaj Medisafe India is ₹3.35 Crs for TTM, ₹3.35 Crs for Mar 2024 and ₹3.34 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Raaj Medisafe India latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech